The Most Important Battle in Gene Editing: CRISPR versus TALEN
Despite all the hype, CRISPR is still not in the clinic as a standalone therapy…
13/03/2018 - 6 minutes
Immuno-oncology
Could This Parisian Biotech Startup’s Cancer Treatment Compete With Merck and Novartis?
Stimunity, a Parisian biotech, secured a 2M€ seed investment to develop a cancer treatment that…
01/03/2018 - 3 minutes
FDA Approves AstraZeneca’s Lung Cancer Treatment after Rejecting Merck and Pfizer’s
The FDA approval will give AstraZeneca a competitive advantage in the lung cancer treatment market over Merck…
21/02/2018 - 2 minutes
Meet the CEO of the Other Big Biotech Acquisition Target in 2017
Christian Schetter’s company, Rigontec, was acquired by MSD last year for nearly half a billion…
29/01/2018 - 9 minutes
Infographic: All You Need to Know About Checkpoint Inhibitors
Everything you need to know about what checkpoint inhibitors are and why they have caused…
10/01/2018 - 2 minutes
German Biotech Raises Record $270M Series A for Individualized Cancer Therapies
BioNTech will dedicate its huge fundraising to develop personalized cancer immunotherapies using CAR-T, TCR and…
04/01/2018 - 2 minutes
Dutch and US Biotechs Team Up Against HPV-related Cancer
ISA Pharmaceuticals will work together with Regeneron to combine its immunotherapy against cancer induced by…
18/12/2017 - 2 minutes
Off-the-Shelf CAR-T Cells Struggle to Improve Cancer Treatment
Data presented at ASH 2017 shows that Servier and Pfizer's UCART19, an allogeneic CAR-T therapy…
13/12/2017 - 4 minutes
Immunotherapy for Uveal Melanoma is on Track for Early Access in the UK
The UK grants Immunocore access to a fast-track scheme that will make its immunotherapy IMCgp100…
12/12/2017 - 2 minutes
Merck and Pfizer’s Checkpoint Inhibitor Fails to Treat Gastric Cancer
Avelumab, marketed as Bavencio by Pfizer and Merck, has failed to show better efficacy than…
29/11/2017 - 2 minutes
This British Biotech Could Treat T-Cell Lymphoma without Leaving the Body Unprotected
Autolus has revealed a new strategy to treat T-cell lymphoma without harming healthy, protective T…
14/11/2017 - 2 minutes
Biotech Unicorn’s T-Cell Receptor Therapy “Nearly Doubles” Survival in Uveal Melanoma
Immunocore, one of the only three European biotech unicorns, has presented Phase I results for…
13/11/2017 - 3 minutes
